Report Categories
View AllRecent Articles
View All
Potential Impact of Ebola Outbreak on Healthcare and Biotech Investments
Mercury Achieves 52 Billion Valuation Following Latest Funding Round Marking 49 Surge in 14 Months
Escalation in Ukraine Conflict Hypersonic Missile Attack Stirs Market Geopolitical Concerns
Bank of America Initiates Coverage on Oklo with Buy Rating Citing Early Leadership in Advanced Nuclear Energy
FPIs Criticize Government and RBI as Rupee Slide and Shrinking Returns Trigger Exit Wave
UK Student Loan Inquiry Garners Over 52000 Grievances Highlighting Mounting Debt Concerns
CorVel Corp CRVL Q1 2026 Earnings EPS of 061 Reported Stock Gains 195
KYN Q4 2015 Earnings Narrow Miss on Estimates Amid Energy Market Headwinds
Kontoor Brands Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick
THM Q1 2026 Earnings Minimal EPS Reported No Revenue as Development Continues
XERS Q1 2026 Earnings EPS Surprise of 21765 as Company Achieves Profitability
Cohen Steers REIT and Preferred and Income Fund RNP Holds Steady Near Key Support Level
Royalty Pharma RPRX Gains 177 as Stock Tests MidRange Levels
Rumble Inc RUM Edges Higher as Support Holds Near 779
PRAX Shows Strength Praxis Precision Medicines Gains 245 as Biotech Momentum Builds
Rithm Capital RITM Holds Steady at 926 Amid Sideways Trading
External Links
Oura Health Inc Confidentially Files for IPO Marking Milestone for Wearable Tech Sector
Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground
Hudson Technologies HDSN Rallies 198 Testing Key Resistance at 542
HCM IV Acquisition Corp Unit HACQU Holds Steady Near Support Amid Quiet Trading
Marchex MCHX Edges Higher as Stock Holds Above Key Support Level
Nuveen AMTFree Municipal Value Fund NUW Edges Higher Amid Steady Demand
Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness
Solaris Energy Infrastructure SEI Advances 148 Key Support and Resistance Levels in Focus
ResMed RMD Holds Steady Minor Decline Amidst RangeBound Trading
Vistagen Therapeutics VTGN Slides 155 as Traders Eye Critical Support at 061